Navigation Links
60 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey
Date:5/28/2008

LONG BRANCH, N.J., May 28 /PRNewswire/ -- To date, 60 specialty & fine chemical and custom synthesis providers from around the world are scheduled to exhibit at the Pharma ChemOutsourcing Conference & Exhibition on September 8-9 in New Jersey.

The conference and exhibition has already attracted more exhibitors at this early date than last September. The supplier community is attracted to the high-quality show that draws an unusually high ratio of attendees from pharmaceutical and biopharmaceutical companies with small molecule outsourcing operations. The annual meeting is experiencing explosive growth.

Exhibitors and Sponsors include:

AIMS Fine Chemicals Johnson Matthey

Almac Jubilant Chemsys

Alphora Research Kalexsyn

Aptuit Mercachem

Ash Stevens NAEJA Pharmaceutical R&D

AstaTech Nissan Chemical

Avra Laboratories Norchim

Bachem Americas Novasep

BoroPharm Inc. Omegachem

Calyx Chemical & Pharmaceutical Onyx Scientific

Cambridge Major Laboratories Pacific World Discovery LLC

CARBOGEN AMCIS AG Paratherm Corporation

Chembiotek Peptech

Chiral Technologies PharmaCore

CiVentiChem ProSynth

Corden Pharmachem Ricerca

Enamine Senn Chemicals

Evonik Degussa Corporation Seres Laboratories

ExelGen Siegfried

GL Chemtec Solvias

GVK BIO Strem Chemical

HEL Ltd SwRI

Helsinn Chemical Operations Syncom

InterChem Corporation
'/>"/>

SOURCE Apaporis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer
2. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
3. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
4. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
5. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
6. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
7. West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference
8. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Isis Awarded $1.5 Million NIH Grant to Improve Chemical Properties of RNAi-Based Therapeutics
11. ADM Forms Industrial Chemicals Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... , September 2, 2015 ... ("BioLight" or the "Company"), a firm that invests ... and cancer diagnostics, announced today that presentations highlighting ... will be delivered at the Ophthalmology Futures European ... Society of Cataract & Refractive Surgeons ("ESCRS"), both ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... members will be attending Pharma Ed Resources upcoming educational seminar and training ... industry leading speakers, this timely conference will provide Updates & Case Studies on ...
(Date:9/1/2015)... 2, 2015 Swecure, ... Forschung und Entwicklung neuartiger Therapien für Störungen ... und Reizdarm konzentriert, erhält vom US Patent ... neues Medikament patentiert wird. Das Medikament basiert ... Kindern verhindert und Entzündungen vorbeugt.   ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2
... 500th patient was supported with the,Berlin Heart EXCOR(R) Pediatric ... the first implantation of the device in 1990. The,patient, ... Memorial,Hospital in Chicago and has been successfully transplanted in ... been diagnosed a few weeks after birth with left,ventricular ...
... ISELIN, N.J., May 28 SyntheMed, Inc. (OTC ... the development and commercialization of anti-adhesion products, announced ... film for the reduction of adhesions following cardiac ... Goods Administration for use in all patients who ...
... Quest Diagnostics scientists will present results of three ... diagnosis and treatment of chronic myeloid leukemia (CML) and ... American Society of Clinical Oncology (ASCO), scheduled for May ... Incorporated (NYSE: DGX ) is the world,s ...
Cached Biology Technology:500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device 2SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R) 2Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 2Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 3Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 4Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 5
(Date:8/20/2015)... Aug. 20, 2015 The wearable technology ... are active and healthy. However, wearable technology has ... environment to help improve diagnostic capabilities and therapeutic ... the Wearable Technologies Conference 2015 , where ... for wearables in healthcare.    "Over ...
(Date:8/19/2015)... , Aug. 19, 2015  VOXX International Corporation ... has entered into a Definitive Agreement to purchase ... iris authentication market leader EyeLock through an acquiring ... have a controlling interest in the acquiring entity. ... completion of due diligence.  Expanding on its existing ...
(Date:8/17/2015)... OXFORD, Conn. , Aug. 17, 2015  NXT-ID, ... a biometric authentication company focused on the growing mobile ... announces its new sales campaign for Q4 2015. The ... winning marketing team consisting of Amplitude Marketing Group ( ... Amplitude Marketing Group is a leader in retail driven ...
Breaking Biology News(10 mins):Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3
... mixing it with sugar, making thick jams that last ... Institute of Standards and Technology (NIST) have discovered* a ... the life of many things including vaccines, food and ... addition to jams, sugars are often used to preserve ...
... unlucky encounter with a crab,s pinchers, consider that the ... times harder than acrylic glass and extremely fracture resistant, ... the U.S. West Coast may have had close encounters ... in a paper published online in advance of regular ...
... not just the climate that is struggling with what humans ... the pressure as well, according to Professor Greg Gibson,s recently ... a Clash Between Our Genes and Modern Life Is Making ... Sciences, suggests the increased rates of diseases such as diabetes, ...
Cached Biology News:Probing and controlling 'molecular rattling' may mean better preservatives 2Crab claws pack strengthening bromide-rich biomaterial 2'It takes a genome: How a clash between our genes and modern life is making us sick' 2
DTT 50 l...
...
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to amino acids 196-244 of E. coli YebU....
Rabbit polyclonal to Peptide E ( Abpromise for all tested applications)....
Biology Products: